Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Tavecchio

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Breast Cancer Research and Treatment|December 3, 2013
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicinWojciech M Ciszewski, Michele Tavecchio, Jarosław Dastych, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracilMonica Ganzinelli, Laura Carrassa, Francesca Crippa, et al.
Frontiers in Medicine|April 18, 2025
A murine pressure ulcer model for evaluating persistence and treatment of <i>Staphylococcus aureus</i> infectionMichele Tavecchio, Silvia Fanni, Xuemin Wu, et al.
Acta Histochemica|December 28, 2007
Multi-parametric flow cytometric cell cycle analysis using TO-PRO-3 iodide (TP3): detailed protocolsMichele Tavecchio, Matteo Simone, Sergio Bernasconi, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2011
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombinationMichele Tavecchio, Joanne M Munck, Celine Cano, et al.
Scientific Reports|October 31, 2015
Deletion of Cyclophilin D Impairs β-Oxidation and Promotes Glucose MetabolismMichele Tavecchio, Sofia Lisanti, Michael J Bennett, et al.
Cancers|October 14, 2022
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular CarcinomaSonia Simón Serrano, Michele Tavecchio, Josef Mallik, et al.
Cell Reports|August 5, 2014
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networksSofia Lisanti, Michele Tavecchio, Young Chan Chae, et al.
Biochemical Pharmacology|December 17, 2009
The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivoDario Brunelli, Michele Tavecchio, Cristiano Falcioni, et al.
Genes & Development|February 22, 2018
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1αSubhasree Basu, Keerthana Gnanapradeepan, Thibaut Barnoud, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|December 3, 2013
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicinWojciech M Ciszewski, Michele Tavecchio, Jarosław Dastych, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracilMonica Ganzinelli, Laura Carrassa, Francesca Crippa, et al.
Frontiers in Medicine|April 18, 2025
A murine pressure ulcer model for evaluating persistence and treatment of <i>Staphylococcus aureus</i> infectionMichele Tavecchio, Silvia Fanni, Xuemin Wu, et al.
Acta Histochemica|December 28, 2007
Multi-parametric flow cytometric cell cycle analysis using TO-PRO-3 iodide (TP3): detailed protocolsMichele Tavecchio, Matteo Simone, Sergio Bernasconi, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2011
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombinationMichele Tavecchio, Joanne M Munck, Celine Cano, et al.
Scientific Reports|October 31, 2015
Deletion of Cyclophilin D Impairs β-Oxidation and Promotes Glucose MetabolismMichele Tavecchio, Sofia Lisanti, Michael J Bennett, et al.
Cancers|October 14, 2022
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular CarcinomaSonia Simón Serrano, Michele Tavecchio, Josef Mallik, et al.
Cell Reports|August 5, 2014
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networksSofia Lisanti, Michele Tavecchio, Young Chan Chae, et al.
Biochemical Pharmacology|December 17, 2009
The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivoDario Brunelli, Michele Tavecchio, Cristiano Falcioni, et al.
Genes & Development|February 22, 2018
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1αSubhasree Basu, Keerthana Gnanapradeepan, Thibaut Barnoud, et al.
Pageof 2